Technology
Health
Biotechnology

Denali Therapeutics

704

$18.94
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.89 (+4.77%) Today
-$0.62 (-3.17%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell DNLI and other stocks, options, ETFs, and crypto commission-free!

About DNLI

Denali Therapeutics Inc. Common Stock, also called Denali Therapeutics, is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Read More Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau. The company was founded by Ryan J. Watts, Marc Tessier-Lavigne, and Alexander Schuth on October 14, 2013 and is headquartered in San Francisco, CA.

CEO
Ryan J. Watts
Employees
261
Headquarters
San Francisco, California
Founded
2013
Market Cap
2.06B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
491.88K
High Today
$19.85
Low Today
$18.85
Open Price
$18.93
Volume
332.90K
52 Week High
$30.41
52 Week Low
$12.39

Collections

Technology
Health
Biotechnology
Therapy
Biopharmaceutical
Pharmaceutical
2017 IPO
US

DNLI Earnings

-$0.61
-$0.14
$0.32
$0.79
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 6, After Hours

People Also Bought

Sangamo Therapeutics

7,421

$7.57

+8.45%

Sangamo Therapeutics

7,421

$7.57

+8.45%

Editas Medicine

10,306

$22.13

+7.38%

CRISPR

29,916

$45.75

+3.09%

Nektar Therapeutics

4,557

$18.78

+1.84%

You May Also Like

VRCA
GJO
BFOR
ACP
EWQ
SIGA
FLCH
FLIR
VRTU
FUE
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy DNLI

Market Price$18.94
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell DNLI stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up